Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Non-Current Assets of $151.7 million for Q1 2026, up 2.58% year-over-year from $147.9 million in Q1 2025, and up 2.88% quarter-over-quarter from $147.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Assets for 17 consecutive years, with $151.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 2.58% year-over-year to $151.7 million; the TTM figure through Mar 2026 stood at $592.7 million (down 0.84% YoY), while the FY2025 annual figure was $147.5 million, down 1.45% from the prior year.
- Non-Current Assets advanced to $151.7 million in Q1 2026 per LMAT's latest filing, from $147.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $152.2 million in Q4 2023 and bottomed at $146.0 million in Q3 2025.
- Historically, Non-Current Assets has averaged $149.8 million across 5 years, with a median of $150.1 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets declined 4.21% — and 2026, when it rose 2.58%.
- Lemaitre Vascular's Non-Current Assets stood at $148.7 million in 2022, then advanced by 2.31% to $152.2 million in 2023, then declined by 1.68% to $149.6 million in 2024, then retreated by 1.45% to $147.5 million in 2025, then advanced by 2.88% to $151.7 million in 2026.
- Business Quant data shows LMAT's Non-Current Assets at $151.7 million in Q1 2026, $147.5 million in Q4 2025, and $146.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 152.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152.25 Mn |
| Mar 31, 2026 | 151.71 Mn |
| Dec 31, 2025 | 147.46 Mn |
| Sep 30, 2025 | 146.04 Mn |
| Jun 30, 2025 | 147.47 Mn |
| Mar 31, 2025 | 147.89 Mn |
| Dec 31, 2024 | 149.63 Mn |
| Sep 30, 2024 | 149.91 Mn |
| Jun 30, 2024 | 150.27 Mn |
| Mar 31, 2024 | 151.00 Mn |
| Dec 31, 2023 | 152.18 Mn |
| Sep 30, 2023 | 151.83 Mn |
| Jun 30, 2023 | 151.98 Mn |
| Mar 31, 2023 | 150.10 Mn |
| Dec 31, 2022 | 148.74 Mn |
| Sep 30, 2022 | 148.91 Mn |
| Jun 30, 2022 | 150.94 Mn |
| Mar 31, 2022 | 151.04 Mn |
| Dec 31, 2021 | 152.92 Mn |
| Sep 30, 2021 | 155.46 Mn |